Laurus Labs shares are at a 52-week high but analysts still see 33% downside

Laurus Labs delivered a strong performance in the first quarter, which was led by another robust quarter in the CDMO division, which grew 7% sequentially.

Leave a Reply

Your email address will not be published. Required fields are marked *